ISSN 0303-5212
 

Original Research 
RMJ. 2022; 47(1): 112-115


Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis

Mamoora Arslaan, Nasim Karim, Mehr Fatima.

Abstract
Objective: To compare clinical efficacy of 1% metformin and alendronate gel in adjunct to scaling and root planning (SRP) on clinical and biochemical parameters in patients having moderate localized chronic periodontitis.
Methodology: In this randomized open label clinical trial, 60 systemically healthy, males and females aged 30-50 year, diagnosed with localized moderate chronic periodontitis were enrolled from Bahria Dental College Hospital by convenient sampling technique. Duration of study was 6 months. Participants with deepest periodontal pocket depth (PPD), clinical attachment loss (CAL), plaque index (PI) and mean sulcular bleeding index (mSBI) were included whereas those with history of periodontal therapy and mouthwashes were excluded. Patients were divided randomly into two groups each group consisting of 30 patients. Group A received Metformin 1% gel and Group B received Alendronate 1% gel, both intra-pocket with SRP at day 0. Clinical parameters were evaluated at day 0, 45 and 90. TNFα was evaluated by Eliza at day 0 and 90. Statistical analysis was done using SPSS version 23.
Results: Group A showed the significant reduction in PPD and CAL compared to group B while PI and mSBI were found non-significant. TNFα was significantly reduced in group A at day 90.
Conclusion: We found that 1% Metformin gel produced more beneficial effects in adjunct to SRP on clinical and biochemical parameters in comparison to 1% Alendronate gel.

Key words: Alendronate, chronic periodontitis, gingival crevicular fluid, Metformin, TNF-α.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mamoora Arslaan
Articles by Nasim Karim
Articles by Mehr Fatima
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. 2022; 47(1): 112-115.


Web Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. https://www.rmj.org.pk/?mno=105679 [Access: December 05, 2023].


AMA (American Medical Association) Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. 2022; 47(1): 112-115.



Vancouver/ICMJE Style

Arslaan M, Karim N, Fatima M. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ. (2022), [cited December 05, 2023]; 47(1): 112-115.



Harvard Style

Arslaan, M., Karim, . N. & Fatima, M. (2022) Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. RMJ, 47 (1), 112-115.



Turabian Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. 2022. Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. Rawal Medical Journal, 47 (1), 112-115.



Chicago Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. "Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis." Rawal Medical Journal 47 (2022), 112-115.



MLA (The Modern Language Association) Style

Arslaan, Mamoora, Nasim Karim, and Mehr Fatima. "Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis." Rawal Medical Journal 47.1 (2022), 112-115. Print.



APA (American Psychological Association) Style

Arslaan, M., Karim, . N. & Fatima, M. (2022) Clinical efficacy of 1% metformin and alendronate intra-pocket gel in moderate localized chronic periodontitis. Rawal Medical Journal, 47 (1), 112-115.